Patients with MASLD frequently exhibit cardiac dysfunction and elevated levels of circulating inflammatory cytokines, including IL-18 and tumor necrosis factor alpha (TNF-α) (6). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.